Journal of Medicinal Chemistry · 2004 · 23 citations · 6 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryLead OptimizationStructure-activity RelationshipsHit-to-lead OptimizationLead Compound DesignPharmacokinetic OptimizationPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisChemical Synthesis Of AnaloguesHistamine H1 Receptor AntagonistsHistamine Receptor AntagonistsHistamine Receptor PharmacologyHistamine ReceptorsIn Vivo StudiesSelectivityStructure - Activity Relationship Optimization
A series of indolylpiperidinyl derivatives were prepared and evaluated for their activity as histamine H(1) antagonists. Structure-activity relationship studies were directed toward improving in vivo activity and pharmacokinetic profile of our first lead (1). Substitution of fluorine in position 6 on the indolyl ring led to higher in vivo activity in the inhibition of histamine-induced cutaneous vascular permeability assay but lower selectivity toward 5HT(2) receptor. Extensive optimization was carried out within this series and a number of histamine H(1) antagonists showing potency and long duration of action in vivo and low brain penetration or cardiotoxic potential were identified. Within this novel series, indolylpiperidines 15, 20, 48,51 and 52 exhibited a long half-life in rat and have been selected for further preclinical evaluation.
6